Pillar Biosciences

About Pillar Biosciences

Pillar Biosciences focuses on transforming NGS (Next-Generation Sequencing) workflows by providing accurate diagnostic technology to medical care providers, aiming to reduce the time to treatment decisions and deliver actionable, accessible results to everyone, everywhere.

Products & Services

VersaTile™, SLIMamp(r), and PiVAT(r) Technologies:Technologies and products that offer a total solution for any NGS laboratory, delivering robust, reliable, and rapid clinical results.

oncoReveal(r) CDx Pan-Cancer Solid Tumor IVD Kit:An FDA-approved diagnostic kit for pan-cancer solid tumor testing.

Specialties

Next-Generation Sequencing (NGS) Diagnostic Technology Cancer Diagnostics

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Funding Round T: - FT: Funding Round	A: 34500000 MR: - FA: $34.5M FAN: 34500000	D: 2025-05-27 FD: 2025-05-27	3 investors

Funding Round Latest

2025-05-27

$34.5M

3 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

G

Gang Song

Founder and Executive Chairman

Z

Zhaohui Wang

Co-founder and Chief Scientific Officer

D

Dan Harma

Chief Commercial Officer

S

Simone Song

Director

J

Jianxin Wang

Director

S

Shawn Liu

Director

View 9 more team members with Pro

Unlock Full Team Directory

Recent News